Phase 3 study of oral lenalidomide as maintenance therapy for patients with B-cell chronic lymphocytic leukemia (CLL).
Asher Alban Akmal Chanan-Khan
No relevant relationships to disclose
Andrey Zaritskey
Honoraria - Novartis
Expert Testimony - Novartis
Miklos Egyed
No relevant relationships to disclose
Samuel Vokurka
Honoraria - Celgene
Olga Samoylova
No relevant relationships to disclose
Anna Schuh
Honoraria - Celgene; Gilead Sciences; GlaxoSmithKline; Roche
Research Funding - GlaxoSmithKline
David Simpson
No relevant relationships to disclose
Jay M. Mei
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Natalia Oliveira
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Oliver Kong
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Robin FoĆ
Honoraria - Celgene
Expert Testimony - Celgene